Cochrane Database Syst Rev (2):CD005646 Demoly P, Messaad D, Sahla H, Fabre J, Faucherre V, Andre P, Reynes J, Godard P, Bousquet J (1998) Six-hour trimethoprim-sulfamethoxazole-graded challenge in HIV-infected patients
TB-500 binds to actin and facilitates this movement
Conclusion In conclusion, this study reveals that excessive GSH intake may contribute to chemotherapy resistance in breast cancer patients, identifying high GSH intake as an independent risk factor for tumor recurrence
This compounded preparation: Has not been approved by the FDA Has not undergone FDA review for safety, effectiveness, or quality Is prepared specifically for you based on your prescriber's order Individual outcomes may vary Dosing is determined by the prescribing provider based on patient-specific factors
24, R453R462